Pharma News

Aspirin lowers risk of cancer in overweight people: Study A regular dose of aspirin can reduce the long-term risk of cancer in those who are overweight, according to an international study of people with a family history of the disease. The study found that being overweight more than doubled the risk of bowel cancer in people with Lynch Syndrome, an inherited ... Read More »

Janssen to develop and commercialize Alligator’s immuno-oncology agent ADC-1013 Janssen Biotech has entered into an exclusive, worldwide license agreement with Swedish biotech firm Alligator Bioscience for ADC-1013, an immuno-oncology agent currently being evaluated in Phase I clinical trials. As part of the deal, Janssen will secure rights to develop and commercialize ADC-1013, an agonistic fully human monoclonal antibody, that targets ... Read More »

Sanofi, Evotec to develop stem cell-based treatments for diabetes French pharmaceutical firm Sanofi has entered strategic research collaboration with German drug discovery firm Evotec for developing beta cell-modulating diabetes treatments, which may reduce or eliminate the need for insulin injections. The company noted that beta cells play a major role in the pathogenesis of diabetes, which currently affects 387 million ... Read More »

India foils UK company’s bid to patent use of turmeric, pine bark and tea for treating hair loss CSIR-TKDL unit also recently foiled an attempt by M/S Colgate-Palmolive Company to patent a mouthwash formula made from Indian herbs India has been successful in protecting its traditional knowledge by preventing an attempt made by Europe’s Leading Dermaceutical Laboratory-Pangaea Laboratories, to take patent ... Read More »

Unichem recalls one lot of hypertension drug in US The recall has been initiated as a precautionary measure due to the identification of a clopidogrel tablet found in a bottle of the product Drug firm Unichem Laboratories is recalling one lot of hydrochlorothiazide tablets, used to treat high blood pressure, in the US market due to the identification of another tablet ... Read More »

Boehringer, Hanmi to develop third generation EGFR targeted therapy in lung cancer Boehringer Ingelheim has entered into an exclusive license and collaboration agreement with Hanmi Pharmaceutical for the development and global commercialisation rights of HM61713, a new third generation EGFR targeted therapy to treat EGFR mutation positive lung cancer. HM61713 is a new 3rd generation, orally active, irreversible EGFR mutation ... Read More »

New drug capsule shells offer new choice: veg or non-veg Veg or non-veg? Not too far in the future, the person asking you that question might just be your neighbourhood chemist. For, a scientific committee advising the Drug Controller General of India (DCGI) may take the next step on Saturday to letting drug manufacturers choose between capsule shells made of ... Read More »

PAREXEL Launches Next Generation Analytics Capabilities within Perceptive MyTrials® Platform PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities.  With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously.  The ... Read More »

Bristol-Myers’ Evotaz gets European approval to treat HIV-1 infection Bristol-Myers Squibb has received approval from the European Commission for Evotaz, a fixed-dose combination of atazanavir and cobicistat, to treat HIV-1 Infection in adults. Evotaz (atazanavir 300mg and cobicistat 150mg) tablets are approved for use in combination with other antiretroviral agents to treat HIV-1 infected adults without known mutations associated with ... Read More »

Chemotherapeutic coatings enhance tumour-frying nanoparticles: Study The photothermal therapy is already being tested for several types of cancers in clinical trials conducted by Nanospectra Biosciences Researchers at Duke University have devised a method for making a promising nanoscale cancer treatment even more deadly to tumours. The invention allows an extremely thin layer of hydrogels (think contact lenses) to be deposited on ... Read More »